Similar articles for PMID: 17941290

Year	Number of Results
1994	1
1998	1
2000	2
2001	3
2002	2
2003	9
2004	6
2005	6
2006	6
2007	9
2008	6
2009	4
2010	5
2011	6
2012	2
2013	3
2014	6
2015	6
2016	4
2018	1
2019	1
2021	1
2024	0

1

The two faces of the 'good' cholesterol.

Ansell BJ. Ansell BJ. Cleve Clin J Med. 2007 Oct;74(10):697-700, 703-5. doi: 10.3949/ccjm.74.10.697. Cleve Clin J Med. 2007. PMID: 17941290 Free article. Review.

2

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM. Hausenloy DJ, et al. Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401. Heart. 2008. PMID: 18480348 Review.

3

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A. Tani S, et al. Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 22149320

4

High-density lipoprotein cholesterol and the role of statins.

Chong PH, Kezele R, Franklin C. Chong PH, et al. Circ J. 2002 Nov;66(11):1037-44. doi: 10.1253/circj.66.1037. Circ J. 2002. PMID: 12419937 Free article. Review.

5

Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes.

Viles-Gonzalez JF, Fuster V, Corti R, Badimon JJ. Viles-Gonzalez JF, et al. Curr Opin Cardiol. 2003 Jul;18(4):286-94. doi: 10.1097/00001573-200307000-00008. Curr Opin Cardiol. 2003. PMID: 12858127 Review.

6

The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.

Puri R, Nissen SE, Shao M, Kataoka Y, Uno K, Kapadia SR, Tuzcu EM, Nicholls SJ. Puri R, et al. Eur J Prev Cardiol. 2016 Mar;23(5):474-85. doi: 10.1177/2047487315572920. Epub 2015 Feb 17. Eur J Prev Cardiol. 2016. PMID: 25691546

7

HDL-C: role as a risk modifier.

Barter P. Barter P. Atheroscler Suppl. 2011 Nov;12(3):267-70. doi: 10.1016/S1567-5688(11)70885-6. Atheroscler Suppl. 2011. PMID: 22152280 Review.

8

Effect of pravastatin on coronary plaque volume.

Ishikawa K, Tani S, Watanabe I, Matsumoto M, Furukawa K, Nomoto K, Nomoto K, Kushiro T, Nagao K, Kanmatsuse K. Ishikawa K, et al. Am J Cardiol. 2003 Oct 15;92(8):975-7. doi: 10.1016/s0002-9149(03)00982-2. Am J Cardiol. 2003. PMID: 14556877

9

Cholesterol, lipids, and statins.

Ballantyne CM. Ballantyne CM. Tex Heart Inst J. 2005;32(3):378-9. Tex Heart Inst J. 2005. PMID: 16392223 Free PMC article. Review.

10

Optimal therapy of low levels of high density lipoprotein-cholesterol.

Kashyap ML, Tavintharan S, Kamanna VS. Kashyap ML, et al. Am J Cardiovasc Drugs. 2003;3(1):53-65. doi: 10.2165/00129784-200303010-00006. Am J Cardiovasc Drugs. 2003. PMID: 14727946 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year